Santos, L.H.; Rocha, R.E.O.; Dias, D.L.; Ribeiro, B.M.R.M.; Serafim, M.S.M.; Abrahão, J.S.; Ferreira, R.S.
Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays. Pharmaceuticals 2023, 16, 1319.
https://doi.org/10.3390/ph16091319
AMA Style
Santos LH, Rocha REO, Dias DL, Ribeiro BMRM, Serafim MSM, Abrahão JS, Ferreira RS.
Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays. Pharmaceuticals. 2023; 16(9):1319.
https://doi.org/10.3390/ph16091319
Chicago/Turabian Style
Santos, Lucianna H., Rafael E. O. Rocha, Diego L. Dias, Beatriz M. R. M. Ribeiro, Mateus Sá M. Serafim, Jônatas S. Abrahão, and Rafaela S. Ferreira.
2023. "Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays" Pharmaceuticals 16, no. 9: 1319.
https://doi.org/10.3390/ph16091319
APA Style
Santos, L. H., Rocha, R. E. O., Dias, D. L., Ribeiro, B. M. R. M., Serafim, M. S. M., Abrahão, J. S., & Ferreira, R. S.
(2023). Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays. Pharmaceuticals, 16(9), 1319.
https://doi.org/10.3390/ph16091319